Kite Pharma's IPO

Kite Pharma raised a round of funding on June 20, 2014. Investors include Public.

Kite Pharma is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on eACT designed to restore the immune system's abilit…

Articles about Kite Pharma's IPO: